Antioxidant and anticancer activities of green synthesized silver nanoparticles using aqueous extract of tubers of Pueraria tuberosa
Source abstract
Abstract
In the present study, we have synthesized silver nanoparticles (AgNPs) using Pueraria tuberosa aqueous extract (PTAE) in a straightforward manner without involvement of toxic chemicals. Various reaction parameters (reaction time, AgNO3 concentration, pH, reaction temperature and PTAE concentration) were optimizeded for the synthesis of AgNPs through visual observation of colour change and absorption peak by UV-Vis spectroscopy. The green synthesized AgNPs were analyzed by DLS, FTIR, SEM, TEM, EDS and XRD for their bio-physical characteristics. The AgNPs were screened for their antioxidant activity by determining total antioxidant capacity (TAC) and anticancer potential by MTT assay. The average particle size of AgNPs was 162.72 ± 5.02 nm with zeta potential of -30.14 ± 2.08 mV. The spherical shape of the AgNPs was confirmed by SEM and TEM. FTIR spectra showed the involvement of different phytoconstituents as capping and stabilizing agents in the synthesis of AgNPs. The TAC of the optimized synthesized AgNPs was more than PTAE. The IC50 of synthesized AgNPs against MCF-7, MDA-MB-231, SKOV-3, U-87 and NCI/ADR cell lines was 3.859, 1.128, 29.36, 6.053 and 25.49 µg/ml, respectively. The green synthesized AgNPs has potential for use in the treatment of different types of cancer.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoparticles: synthesis and applications · Moringa oleifera research and applications · Medicinal Plant Research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Pharmaceutical & Biomedical Sciences, College of Pharmacy, California Health Sciences University
Institute of Pharmacy, Guru Ghasidas University
References (41)
Show source-provided references
1. Singh P, Kim YJ, Wang C, et al. Biogenic silver and gold nanoparticles synthesized using red ginseng root extract, and their applications. Artif Cells Nanomed Biotechnol. 2016;44:1–816.
2. 10.1016/j.tibtech.2010.07.00610.1016/j.tibtech.2010.07.006 ↗
3. 10.1016/j.plantsci.2010.04.01210.1016/j.plantsci.2010.04.012 ↗
4. 10.1016/j.jphotobiol.2016.12.01310.1016/j.jphotobiol.2016.12.013 ↗
5. 10.1016/j.colsurfa.2010.07.02410.1016/j.colsurfa.2010.07.024 ↗
6. 10.1021/jp012668l10.1021/jp012668l ↗
7. 10.1016/j.colsurfa.2004.12.05810.1016/j.colsurfa.2004.12.058 ↗
8. 10.1021/jp991569t10.1021/jp991569t ↗
9. 10.1039/C6NJ03454C10.1039/C6NJ03454C ↗
10. 10.1021/la020835i10.1021/la020835i ↗
11. 10.1002/jctb.242710.1002/jctb.2427 ↗
12. 10.1016/j.jgr.2013.11.00110.1016/j.jgr.2013.11.001 ↗
13. 10.1080/17518253.2016.119269210.1080/17518253.2016.1192692 ↗
14. 10.3390/ijms1709153410.3390/ijms17091534 ↗
15. 10.1080/14786419.2014.92829110.1080/14786419.2014.928291 ↗
16. Venkatasubramanian P, Subrahmanya KK, Venugopal SN. Use of Ksiravidari as a substitute for Vidari as per Ayurvedic descriptions. Indian J Tradit Knowledge. 2009;8:310–318.
17. 10.1080/10826076.2017.132974310.1080/10826076.2017.1329743 ↗
18. Khandelwal KR. Practical pharmacognosy. Pune: Nirali Prakashan; 2002.
19. Patra A, Jha S, Murthy PN. Pharmacognostical standardization of leaves of Hygrophila spinosa T. Anders. Pharmacog J 2009;1:82–87.
20. 10.4103/0250-474X.10024210.4103/0250-474X.100242 ↗
21. 10.1166/jnn.2017.1263610.1166/jnn.2017.12636 ↗
22. 10.1016/j.jsps.2016.05.00710.1016/j.jsps.2016.05.007 ↗
23. 10.1039/C4CS00363B10.1039/C4CS00363B ↗
24. 10.7314/APJCP.2014.15.10.431110.7314/APJCP.2014.15.10.4311 ↗
25. 10.1021/np990450910.1021/np9904509 ↗
26. 10.1016/j.matlet.2015.12.03110.1016/j.matlet.2015.12.031 ↗
27. 10.1007/s00449-008-0224-610.1007/s00449-008-0224-6 ↗
28. 10.1016/j.indcrop.2013.04.00110.1016/j.indcrop.2013.04.001 ↗
29. 10.1039/C5NJ02367J10.1039/C5NJ02367J ↗
30. 10.2174/092986704336518910.2174/0929867043365189 ↗
31. 10.1155/2015/23474110.1155/2015/234741 ↗
32. 10.3109/21691401.2016.116040310.3109/21691401.2016.1160403 ↗
33. 10.2147/IJN.S5734310.2147/IJN.S57343 ↗
34. Honary S, Zahir F. Effect of zeta potential on the properties of nano-drug delivery systems – a review (Part 2). Trop J Pharm Res. 2013;12:265–273.
35. Yue PF, Yuan HL, Yang M, et al. Preparation, characterization, and pharmacokinetic evaluation of puerarin submicron emulsion. PDA J Pharm Sci Technol. 2008;62:32–45.
36. 10.1016/j.saa.2014.06.04610.1016/j.saa.2014.06.046 ↗
37. 10.1002/cbdv.20079000110.1002/cbdv.200790001 ↗
38. 10.1186/s11671-017-1833-210.1186/s11671-017-1833-2 ↗
39. 10.2147/IJN.S11837310.2147/IJN.S118373 ↗
40. Gabizon AA. Selective tumor localization and improved therapeutic index of anthracyclines encapsulated in long-circulating liposomes. Cancer Res 1992;52:891–896.
41. 10.1016/j.ijpharm.2009.04.03010.1016/j.ijpharm.2009.04.030 ↗